Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Dickerson

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Steroids|March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomesEric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
American Journal of Public Health|April 24, 2015
Beyond health equity: achieving wellness within American Indian and Alaska Native communitiesValarie Blue Bird Jernigan, Michael Peercy, Dannielle Branam, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|August 1, 2023
Including Community Partners in the Development and Adaptation of Intervention Strategies to Prevent Initiation or Escalation of Opioid MisuseRebecca Perry, Elvira Elek, Elizabeth D'Amico, et al.
British Journal of Clinical Pharmacology|February 6, 2020
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologicsAnne Bellon, Jessie Wang, Andrej Skerjanec, et al.
Clinical Pharmacology and Therapeutics|September 2, 2024
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986308: A Renal Outer Medullary Potassium Channel InhibitorSharif I Soleman, Juan Maya, Paul Levesque, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Steroids|March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomesEric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
American Journal of Public Health|April 24, 2015
Beyond health equity: achieving wellness within American Indian and Alaska Native communitiesValarie Blue Bird Jernigan, Michael Peercy, Dannielle Branam, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|August 1, 2023
Including Community Partners in the Development and Adaptation of Intervention Strategies to Prevent Initiation or Escalation of Opioid MisuseRebecca Perry, Elvira Elek, Elizabeth D'Amico, et al.
British Journal of Clinical Pharmacology|February 6, 2020
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologicsAnne Bellon, Jessie Wang, Andrej Skerjanec, et al.
Clinical Pharmacology and Therapeutics|September 2, 2024
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986308: A Renal Outer Medullary Potassium Channel InhibitorSharif I Soleman, Juan Maya, Paul Levesque, et al.
Pageof 3